Showing results (151-160 of 608) with videos related to
Sort By:
Pageof 61
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Long-term treatment with low dose naltrexone maintains stable health in patients with multiple sclerosisMichael D Ludwig, Anthony P Turel, Ian S Zagon, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Analysis of the psychometric properties of the Multiple Sclerosis Impact Scale-29 (MSIS-29) in relapsing-remitting multiple sclerosis using classical and modern test theoryE D Bacci, K W Wyrwich, G A Phillips, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Relapsing optic neuritis and isolated transverse myelitis are the predominant clinical phenotypes for patients with antibodies to myelin oligodendrocyte glycoprotein in IndiaLekha Pandit, Douglas Kazutoshi Sato, Sharik Mustafa, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Improvement in relapse recovery with peginterferon beta-1a in patients with multiple sclerosisThomas F Scott, Bernd C Kieseier, Scott D Newsome, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Skeletal muscle mitochondrial capacity in people with multiple sclerosisMary Ann Harp, Kevin K McCully, Marina Moldavskiy, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Randomized controlled trial of exercise interventions to improve sleep quality and daytime sleepiness in individuals with multiple sclerosis: A pilot studyCatherine F Siengsukon, Mayis Aldughmi, Melike Kahya, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Noninvasive tongue stimulation combined with intensive cognitive and physical rehabilitation induces neuroplastic changes in patients with multiple sclerosis: A multimodal neuroimaging studyGabriel Leonard, Yves Lapierre, Jen-Kai Chen, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Assessment of treatment patterns associated with injectable disease-modifying therapy among relapsing-remitting multiple sclerosis patientsJ Nicholas, J J Ko, Y Park, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Enhanced disease reduction using clozapine, an atypical antipsychotic agent, and glatiramer acetate combination therapy in experimental autoimmune encephalomyelitisLaura K Green, Pirooz Zareie, Nikki Templeton, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Access and barriers to MS care in Latin AmericaVíctor M Rivera, Miguel Angel MaciasPageof 61